XenoPort, Inc
Article Abstract:
The price appreciation potential of the shares of XenoPort Inc. for the years 2010-2012 is discussed. The Santa Clara, California-based firm is a development-stage pharmaceutical company which focuses on treating neurological/psychiatric disorders.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
XenoPort Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
King Pharm
Article Abstract:
The price appreciation potential of the shares of King Pharmaceuticals Inc. for the years 2010-2012 is discussed. The Bristol, Tennessee-based company develops, manufactures, markets, and sells branded prescription drug products.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
King Pharmaceuticals Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Pharmaceutical industry, Stocks, Securities, Stock prices, Company securities, Analyst report
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.